X @Bloomberg
Eli Lilly’s weight-loss drug underperformed in trials, sending its shares down and boosting Novo Nordisk’s stock https://t.co/UxkQixYEBD ...
Eli Lilly’s weight-loss drug underperformed in trials, sending its shares down and boosting Novo Nordisk’s stock https://t.co/UxkQixYEBD ...